Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
2) parenteral nutrition components acting as toxic or the lack of specific nutrients and 3) those due to the underlying disease
A new safety signal emerged: dysesthesia (abnormal sense of touch) affected 20.9% of patients on the highest dose, though it was generally mild
Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance
J Immunol Res (2018) 2018:9412387
It is not medical advice, diagnosis, or treatment guidance
US$ 29.30
US$ 26.34
US$ 23.58
US$ 27.26
US$ 25.05
US$ 22.82
US$ 20.48
US$ 20.86
US$ 27.65
US$ 25.72
